Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 14, 2003, Pages 8543-8548

  Wilkemeyer, Michael F ^a,b,c   Chen, Shao yu ^d   Menkari, Carrie E ^a,b,c   Brenneman, Douglas E ^e   Sulik, Kathleen K ^d   Charness, Michael E ^a,b,c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALANYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; ALCOHOL; ASPARAGINYLALANYLALANYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; ASPARAGINYLALANYLPROLYLALANYLSERYLISOLEUCYLPROLYLGLUTAMINE; ASPARAGINYLALANYLPROLYLVALYLALANYLISOLEUCYLPROLYLGLUTAMINE; ASPARAGINYLALANYLPROLYLVALYLSERYLALANYLPROLYLGLUTAMINE; ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLALANYLGLUTAMINE; ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLALANINE; ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; CALGRANULIN; ISOLEUCINE; PEPTIDE FRAGMENT; PROLINE; SERINE; TETRODOTOXIN; UNCLASSIFIED DRUG;

ALCOHOL INTOXICATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ADHESION; CELL STRAIN 3T3; CHEMICAL TERATOGENESIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EFFICACY; DRUG POTENCY; EMBRYO; EMBRYO CULTURE; EMBRYOTOXICITY; FETAL ALCOHOL SYNDROME; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; SOMITE; STRUCTURE ACTIVITY RELATION;

ABNORMALITIES, DRUG-INDUCED; AMINO ACID SUBSTITUTION; ANIMALS; CELL ADHESION; EMBRYO; ETHANOL; FEMALE; HOMEODOMAIN PROTEINS; MICE; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; NEURAL CELL ADHESION MOLECULE L1; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PREGNANCY; STRUCTURE-ACTIVITY RELATIONSHIP; TETRODOTOXIN;

ANIMALIA;

EID: 0037899135     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.1331636100     Document Type: Article

References (46)

1. Abel, E. L. & Sokol, R. J, (1987) Drug Alcohol Depend. 19, 51-70.
2. Diamond, I. & Gordon, A. S. (1997) Physiol. Rev. 77, 1-20.
3. Gressens, P., Lammens, M., Picard, J. J. & Evrard, P. (1992) Alcohol Alcohol. 27, 219-226.
4. Kotch, L. E., Chen, S. Y. & Sulik, K. K. (1995) Teratology 52, 128-136.
5. Guerri, C., Pascual, M. & Renau-Piqueras, J. (2001) Neurotoxicology 22, 593-599.
6. Climent, E., Pascual, M., Renau-Piqueras, J. & Guerri, C. (2002) J. Neurosci. Res. 68, 213-225.
7. Ramanathan, R., Wilkemeyer, M. F., Mittal, B., Perides, G. & Charness, M. E. (1996) J. Cell Biol. 133, 381-390.
8. Ikonomidou, C., Bittigau, P., Ishimaru, M. J., Wozniak, D. F., Koch, C., Genz, K., Price, M. T., Stefovska, V., Horster, F., Tenkova, T., et al. (2000) Science 287, 1056-1060.
9. Mitchell, J. J., Paiva, M. & Heaton, M. B. (1999) Neurosci. Lett. 263, 189-192.
10. Goodlett, C. R. & Horn, K. H. (2001) Alcohol Res. Health 25, 175-184.
11. Chen, S.-Y., Wilkemeyer, M. F., Sulik, K. K. & Charness, M. E. (2001) FASEB J. 15, 1649-1651.
12. Spong, C. Y., Abebe, D. T., Gozes, I., Brenneman, D. E. & Hill, J. M. (2001) J. Pharmacol. Exp. Ther. 297, 774-779.
13. Charness, M. E., Safran, R. M. & Perides, G. (1994). J. Biol. Chem. 269, 9304-9309.
14. Wilkemeyer, M. F. & Charness, M. E. (1998) J. Neurochem, 71, 2382-2391.
15. Bearer, C. F., Swick, A. R., O'Riordan, M. A. & Cheng, G. (1999) J. Biol. Chem. 274, 13264-13270.
16. Wilkemeyer, M. F., Sebastian, A. B., Smith. S. A. & Charness, M. E. (2000) Proc. Natl. Acad. Sci. USA 97, 3690-3695.
17. Wilkemeyer, M. F., Menkari, C. E. & Charness, M. E. (2002) Mol. Pharmacol. 62, 1053-1060.
18. Brenneman, D. E., Hauser, J., Neale, E., Rubinraut, S., Fridkin, M., Davidson, A. & Gozes, I. (1998) J. Pharmacol. Exp. Ther. 285, 619-627.
19. Bassan, M., Zamostiano, R., Davidson, A., Pinhasov, A., Giladi, E., Perl, O., Bassan, H., Blat, C., Gibney, G., Glazner, G., et al. (1999) J. Neurochem. 72, 1283-1293.
20. Zamostiano, R., Pinhasov, A., Bassan, M., Perl, O., Steingart, R. A., Atlas, R., Brenneman, D. E. & Gozes, I. (1999) Neurosci. Lett. 264, 9-12.
21. Glazner, G. W., Boland, A., Dresse, A. E., Brenneman, D. E., Gozes, I. & Mattson, M. P. (1999) J. Neurochem. 73, 2341-2347.
22. Gressens, P., Marret, S., Hill, J. M., Brenneman, D. E., Gozes, I., Fridkin, M. & Evrard, P. (1997) J. Clin. Invest. 100, 390-397.
23. Beni-Adani, L., Gozes, I., Cohen, Y., Assaf, Y., Steingart, R. A., Brenneman, D. E., Eizenberg, O., Trembolver, V. & Shohami, E. (2001) J. Pharmacol. Exp. Ther. 296, 57-63.
24. Leker, R. R., Teichner, A., Grigoriadis, N., Ovadia, H., Brenneman, D. E., Fridkin, M., Giladi, E., Romano, J. & Gozes, I. (2002) Stroke (Dallas) 33, 1085-1092.
25. Gozes, I., Giladi, E., Pinhasov, A., Bardea, A. & Brenneman, D. E. (2000) J. Pharmacol. Exp. Ther. 293, 1091-1098.
26. Ashur-Fabian, O., Giladi, E., Furman, S., Steingart, R. A., Wollman, Y., Fridkin, M., Brenneman, D. E. & Gozes, I. (2001) Neurosci. Lett. 307, 167-170.
27. Blondel, O., Collin, C., McCarran, W. J., Zhu, S., Zamostiano, R., Gozes, I., Brenneman, D. E. & McKay, R. D. (2000) J. Neurosci. 20, 8012-8020.
28. Gressens, P., Marret, S., Bodenant, C., Schwendimann, L. & Evrard, P. (1999) J. Mol. Neurosci. 13, 199-210.
29. Glazner, G. W., Carnandola, S. & Mattson, M. P. (2000) J. Neurochem. 75, 101-108.
30. Offen, D., Sherki, Y., Melamed, E., Fridkin, M., Brenneman, D. E. & Gozes, I. (2000) Brain Res. 854, 257-262.
31. Steingart, R. A., Solomon, B., Brenneman, D. E., Fridkin, M. & Gozes, I. (2000) J. Mol. Neurosci. 15, 137-145.
32. Wilkemeyer, M. F., Menkari, C., Spong, C. Y. & Charness, M. E. (2002) J. Pharmacol. Exp. Ther. 303, 110-116.
33. Wilkemeyer, M. F., Pajerski, M. & Charness, M. E. (1999) Alcohol. Clin. Exp. Res. 23, 1711-1720.
34. McCarthy, K. D. & de Vellis, J. (1980) J. Cell Biol. 85, 890-902.
35. Brenneman, D. E. & Foster, G. A. (1987) Peptides (Tarrytown, NY) 8, 687-694.
36. Romijn, H. J., van Huizen, F. & Wolters, P. S. (1984) Neurosci. Biobehav. Rev. 8, 301-334.
37. Schmechel, D., Marangos, P. J., Zis, A. P., Brightman, M. & Goodwin, F. K. (1978) Science 199, 313-315.
38. Ransom, B. R. & Holz, R. W. (1977) Brain Res. 136, 445-453.
39. Brenneman, D. E. (1986) Can. J. Physiol. Pharmacol. 64, 356-362.
40. Brenneman, D. E., Neale, E. A., Habig, W. H., Bowers, L. M. & Nelson, P. G. (1983) Brain Res. 285, 13-27.
41. Sulik, K. K., Johnston, M. C. & Webb, M. A. (1981) Science 214, 936-938.
42. Kotch, L. E. & Sulik, K. K. (1992) Int. J. Dev. Neurosci. 10, 273-279.
43. Zemlyak, I., Furman, S., Brenneman, D. E. & Gozes, I. (2000) Regul. Pept. 96, 39-43.
44. Brenneman, D. E. & Gozes, I. (1996) J. Clin. Invest. 97, 2299-2307.
45. Charness, M. E., Simon, R. P. & Greenberg, D. A. (1989) N. Engl. J. Med. 321, 442-454.
46. Kotch, L. E., Dehart, D. B., Alles, A. J., Chernoff, N. & Sulik, K. K. (1992) Teratology 46, 323-332.